Prosecution Insights
Last updated: September 07, 2026

Examiner: FONTAINHAS, AURORA M

Tech Center 1600 • Art Units: 1649 1674 1675

This examiner grants 38% of resolved cases

Performance Statistics

38.0%
Allow Rate
-22.0% vs TC avg
539
Total Applications
+49.1%
Interview Lift
1190
Avg Prosecution Days
Based on 495 resolved cases, 2023–2026

Rejection Statute Breakdown

9.6%
§101 Eligibility
14.1%
§102 Novelty
31.6%
§103 Obviousness
24.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
16980679 METHODS FOR TREATING OCULAR DISEASES Non-Final OA Novartis AG
17780846 MEASUREMENT METHOD AND MEASUREMENT REAGENT FOR ANALYTE USING IMMUNOREACTION Non-Final OA SEKISUI MEDICAL CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month